Maggie McMullen

Maggie McMullen has a diverse background in business development and sales within the pharmaceutical and biotechnology industries. Maggie started their career as a Territory Account Manager at XenoTech LLC in 2000 and later became a Staff Scientist in the enzyme induction department.

In 2006, Maggie transitioned to ProImmune as a Technical Sales Representative before returning to XenoTech LLC as an Executive Account Manager/Commercial Operations from 2007 to 2013. During this time, they also managed the North American based Account Management team.

From 2014 to 2015, Maggie held positions as a Business Development Manager at Frontage Laboratories and Coté Orphan LLC. Maggie then served as the Director of Business Development at Qualyst Transporter Solutions from 2015 to 2018.

From 2016 to 2022, Maggie was a Business Development Advisor at RareMoon | Orphan Product Development. Maggie then joined Lovelace Biomedical as a Business Development Operations Manager before being promoted to Business Development Operations Director in 2022.

Currently, Maggie holds the position of Chief Business Development Officer at Alturas Analytics Inc., a Contract Research Organization specializing in preclinical and clinical bioanalysis.

Throughout their career, Maggie has demonstrated expertise in building client relationships, increasing sales, and providing expert solutions to meet unique bioanalytical needs.

Maggie McMullen obtained a Bachelor's degree in Zoology from the University of Wisconsin-Madison from 1992 to 1996. Maggie also completed a program at the American Management Association from 2011 to 2012, although no degree or field of study information was provided.